nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP2B6—Thiotepa—sarcoma	0.109	0.192	CbGbCtD
Amitriptyline—CYP2E1—Dacarbazine—sarcoma	0.0614	0.108	CbGbCtD
Amitriptyline—CYP2E1—Mitoxantrone—sarcoma	0.0477	0.0837	CbGbCtD
Amitriptyline—CYP1A2—Dacarbazine—sarcoma	0.0355	0.0624	CbGbCtD
Amitriptyline—CYP3A4—Thiotepa—sarcoma	0.0336	0.059	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—sarcoma	0.0301	0.0528	CbGbCtD
Amitriptyline—ABCB1—Dactinomycin—sarcoma	0.0269	0.0473	CbGbCtD
Amitriptyline—CYP3A5—Vincristine—sarcoma	0.0255	0.0448	CbGbCtD
Amitriptyline—ABCB1—Mitoxantrone—sarcoma	0.0241	0.0423	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—sarcoma	0.0234	0.041	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—sarcoma	0.0225	0.0395	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—sarcoma	0.0202	0.0355	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—sarcoma	0.0174	0.0305	CbGbCtD
Amitriptyline—ABCB1—Vincristine—sarcoma	0.0166	0.0291	CbGbCtD
Amitriptyline—ABCB1—Etoposide—sarcoma	0.0152	0.0267	CbGbCtD
Amitriptyline—CYP3A4—Mitoxantrone—sarcoma	0.0144	0.0254	CbGbCtD
Amitriptyline—HTR1D—meninx—sarcoma	0.0129	0.0999	CbGeAlD
Amitriptyline—HTR1B—dura mater—sarcoma	0.0123	0.0949	CbGeAlD
Amitriptyline—HTR1D—dura mater—sarcoma	0.0119	0.0919	CbGeAlD
Amitriptyline—ABCB1—Doxorubicin—sarcoma	0.0104	0.0182	CbGbCtD
Amitriptyline—CYP3A4—Vincristine—sarcoma	0.00994	0.0175	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—sarcoma	0.00977	0.0172	CbGbCtD
Amitriptyline—CYP3A4—Etoposide—sarcoma	0.00911	0.016	CbGbCtD
Amitriptyline—CYP3A4—Doxorubicin—sarcoma	0.00621	0.0109	CbGbCtD
Amitriptyline—CHRM3—muscle of abdomen—sarcoma	0.00502	0.0388	CbGeAlD
Amitriptyline—NTRK2—mammary gland—sarcoma	0.00447	0.0346	CbGeAlD
Amitriptyline—HTR7—pulmonary artery—sarcoma	0.00404	0.0313	CbGeAlD
Amitriptyline—HRH4—hematopoietic system—sarcoma	0.00291	0.0225	CbGeAlD
Amitriptyline—NTRK2—connective tissue—sarcoma	0.00262	0.0203	CbGeAlD
Amitriptyline—HTR2A—pulmonary artery—sarcoma	0.00252	0.0195	CbGeAlD
Amitriptyline—KCND2—myometrium—sarcoma	0.0021	0.0162	CbGeAlD
Amitriptyline—NTRK1—testis—sarcoma	0.00195	0.0151	CbGeAlD
Amitriptyline—HRH4—bone marrow—sarcoma	0.00187	0.0144	CbGeAlD
Amitriptyline—NTRK2—bone marrow—sarcoma	0.00175	0.0135	CbGeAlD
Amitriptyline—HTR2A—hindlimb—sarcoma	0.00153	0.0118	CbGeAlD
Amitriptyline—NTRK2—testis—sarcoma	0.00149	0.0115	CbGeAlD
Amitriptyline—HTR2A—appendage—sarcoma	0.00131	0.0101	CbGeAlD
Amitriptyline—HTR7—endothelium—sarcoma	0.00127	0.00979	CbGeAlD
Amitriptyline—ALB—mammary gland—sarcoma	0.00124	0.00957	CbGeAlD
Amitriptyline—HRH2—hematopoietic system—sarcoma	0.00122	0.00945	CbGeAlD
Amitriptyline—SIGMAR1—mammary gland—sarcoma	0.00119	0.00923	CbGeAlD
Amitriptyline—KCND3—cardiac atrium—sarcoma	0.00119	0.00921	CbGeAlD
Amitriptyline—KCND3—uterus—sarcoma	0.00119	0.00916	CbGeAlD
Amitriptyline—NTRK2—lymph node—sarcoma	0.00108	0.00837	CbGeAlD
Amitriptyline—HRH2—skin of body—sarcoma	0.00106	0.00822	CbGeAlD
Amitriptyline—KCNA1—tendon—sarcoma	0.00104	0.00807	CbGeAlD
Amitriptyline—KCNQ2—testis—sarcoma	0.00104	0.00805	CbGeAlD
Amitriptyline—CHRM5—skin of body—sarcoma	0.00102	0.00785	CbGeAlD
Amitriptyline—KCND2—testis—sarcoma	0.000987	0.00762	CbGeAlD
Amitriptyline—HRH2—cardiac atrium—sarcoma	0.000929	0.00718	CbGeAlD
Amitriptyline—OPRM1—hematopoietic system—sarcoma	0.000881	0.00681	CbGeAlD
Amitriptyline—CYP2C8—mammary gland—sarcoma	0.00087	0.00672	CbGeAlD
Amitriptyline—ORM1—hematopoietic system—sarcoma	0.00086	0.00665	CbGeAlD
Amitriptyline—KCND3—testis—sarcoma	0.00086	0.00665	CbGeAlD
Amitriptyline—SIGMAR1—myometrium—sarcoma	0.000848	0.00655	CbGeAlD
Amitriptyline—CHRM4—testis—sarcoma	0.000819	0.00633	CbGeAlD
Amitriptyline—KCND3—liver—sarcoma	0.000813	0.00628	CbGeAlD
Amitriptyline—HTR2A—endothelium—sarcoma	0.00079	0.0061	CbGeAlD
Amitriptyline—CYP2C9—mammary gland—sarcoma	0.000773	0.00597	CbGeAlD
Amitriptyline—SIGMAR1—seminal vesicle—sarcoma	0.000766	0.00592	CbGeAlD
Amitriptyline—HTR1D—connective tissue—sarcoma	0.000752	0.00581	CbGeAlD
Amitriptyline—SLC6A4—hematopoietic system—sarcoma	0.000733	0.00566	CbGeAlD
Amitriptyline—HTR1A—hematopoietic system—sarcoma	0.000651	0.00503	CbGeAlD
Amitriptyline—SIGMAR1—smooth muscle tissue—sarcoma	0.000641	0.00495	CbGeAlD
Amitriptyline—HRH2—liver—sarcoma	0.000634	0.0049	CbGeAlD
Amitriptyline—KCND3—lymph node—sarcoma	0.000624	0.00482	CbGeAlD
Amitriptyline—HTR7—hematopoietic system—sarcoma	0.000622	0.00481	CbGeAlD
Amitriptyline—CYP2C19—hematopoietic system—sarcoma	0.000607	0.00469	CbGeAlD
Amitriptyline—ADRA1A—hematopoietic system—sarcoma	0.0006	0.00464	CbGeAlD
Amitriptyline—HTR7—connective tissue—sarcoma	0.000599	0.00463	CbGeAlD
Amitriptyline—CHRM3—smooth muscle tissue—sarcoma	0.000576	0.00445	CbGeAlD
Amitriptyline—SIGMAR1—cardiac atrium—sarcoma	0.000553	0.00427	CbGeAlD
Amitriptyline—ORM1—bone marrow—sarcoma	0.000551	0.00426	CbGeAlD
Amitriptyline—SIGMAR1—uterus—sarcoma	0.00055	0.00425	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—sarcoma	0.000548	0.00423	CbGeAlD
Amitriptyline—HRH1—myometrium—sarcoma	0.000541	0.00418	CbGeAlD
Amitriptyline—ADRA2A—myometrium—sarcoma	0.000531	0.00411	CbGeAlD
Amitriptyline—CYP2C8—hematopoietic system—sarcoma	0.00053	0.0041	CbGeAlD
Amitriptyline—Discomfort—Dactinomycin—sarcoma	0.000516	0.0031	CcSEcCtD
Amitriptyline—Confusional state—Thiotepa—sarcoma	0.000508	0.00306	CcSEcCtD
Amitriptyline—Hypoaesthesia—Etoposide—sarcoma	0.000507	0.00305	CcSEcCtD
Amitriptyline—Agitation—Vincristine—sarcoma	0.000503	0.00303	CcSEcCtD
Amitriptyline—Vision blurred—Mitoxantrone—sarcoma	0.000503	0.00303	CcSEcCtD
Amitriptyline—Oedema—Dactinomycin—sarcoma	0.0005	0.00301	CcSEcCtD
Amitriptyline—CYP1A2—hematopoietic system—sarcoma	0.000496	0.00383	CbGeAlD
Amitriptyline—Ill-defined disorder—Mitoxantrone—sarcoma	0.000495	0.00298	CcSEcCtD
Amitriptyline—Mental disability—Epirubicin—sarcoma	0.000494	0.00297	CcSEcCtD
Amitriptyline—Thrombocytopenia—Thiotepa—sarcoma	0.000494	0.00297	CcSEcCtD
Amitriptyline—Tachycardia—Thiotepa—sarcoma	0.000492	0.00296	CcSEcCtD
Amitriptyline—Leukopenia—Vincristine—sarcoma	0.00049	0.00295	CcSEcCtD
Amitriptyline—Thrombocytopenia—Dactinomycin—sarcoma	0.00049	0.00295	CcSEcCtD
Amitriptyline—HRH2—lymph node—sarcoma	0.000486	0.00376	CbGeAlD
Amitriptyline—OPRM1—testis—sarcoma	0.000483	0.00373	CbGeAlD
Amitriptyline—SIGMAR1—tendon—sarcoma	0.000482	0.00372	CbGeAlD
Amitriptyline—Malaise—Mitoxantrone—sarcoma	0.000481	0.00289	CcSEcCtD
Amitriptyline—Coma—Doxorubicin—sarcoma	0.000481	0.00289	CcSEcCtD
Amitriptyline—Anorexia—Thiotepa—sarcoma	0.000481	0.00289	CcSEcCtD
Amitriptyline—ADRA2A—seminal vesicle—sarcoma	0.00048	0.00371	CbGeAlD
Amitriptyline—CYP3A5—hematopoietic system—sarcoma	0.000478	0.0037	CbGeAlD
Amitriptyline—Leukopenia—Mitoxantrone—sarcoma	0.000478	0.00287	CcSEcCtD
Amitriptyline—Anorexia—Dactinomycin—sarcoma	0.000477	0.00287	CcSEcCtD
Amitriptyline—CYP2B6—hematopoietic system—sarcoma	0.000476	0.00367	CbGeAlD
Amitriptyline—Convulsion—Vincristine—sarcoma	0.000475	0.00286	CcSEcCtD
Amitriptyline—Hypertension—Vincristine—sarcoma	0.000473	0.00285	CcSEcCtD
Amitriptyline—CYP2C9—hematopoietic system—sarcoma	0.000471	0.00364	CbGeAlD
Amitriptyline—CYP2E1—seminal vesicle—sarcoma	0.00047	0.00363	CbGeAlD
Amitriptyline—SIGMAR1—bone marrow—sarcoma	0.000467	0.00361	CbGeAlD
Amitriptyline—HRH1—hematopoietic system—sarcoma	0.000464	0.00359	CbGeAlD
Amitriptyline—Convulsion—Mitoxantrone—sarcoma	0.000462	0.00278	CcSEcCtD
Amitriptyline—Vascular purpura—Epirubicin—sarcoma	0.000462	0.00278	CcSEcCtD
Amitriptyline—Hypertension—Mitoxantrone—sarcoma	0.000461	0.00277	CcSEcCtD
Amitriptyline—Hepatic failure—Epirubicin—sarcoma	0.00046	0.00277	CcSEcCtD
Amitriptyline—Mental disability—Doxorubicin—sarcoma	0.000457	0.00275	CcSEcCtD
Amitriptyline—ADRA2A—hematopoietic system—sarcoma	0.000456	0.00352	CbGeAlD
Amitriptyline—Paraesthesia—Thiotepa—sarcoma	0.000453	0.00272	CcSEcCtD
Amitriptyline—Anxiety—Mitoxantrone—sarcoma	0.000453	0.00272	CcSEcCtD
Amitriptyline—Alopecia—Etoposide—sarcoma	0.00045	0.00271	CcSEcCtD
Amitriptyline—Discomfort—Mitoxantrone—sarcoma	0.000449	0.0027	CcSEcCtD
Amitriptyline—Somnolence—Thiotepa—sarcoma	0.000448	0.0027	CcSEcCtD
Amitriptyline—HRH1—connective tissue—sarcoma	0.000447	0.00346	CbGeAlD
Amitriptyline—Oedema—Vincristine—sarcoma	0.000447	0.00269	CcSEcCtD
Amitriptyline—CYP2E1—hematopoietic system—sarcoma	0.000446	0.00345	CbGeAlD
Amitriptyline—ORM1—liver—sarcoma	0.000446	0.00344	CbGeAlD
Amitriptyline—Dyspepsia—Thiotepa—sarcoma	0.000444	0.00267	CcSEcCtD
Amitriptyline—ADRA2A—connective tissue—sarcoma	0.000439	0.00339	CbGeAlD
Amitriptyline—Confusional state—Mitoxantrone—sarcoma	0.000439	0.00264	CcSEcCtD
Amitriptyline—Decreased appetite—Thiotepa—sarcoma	0.000438	0.00264	CcSEcCtD
Amitriptyline—Thrombocytopenia—Vincristine—sarcoma	0.000438	0.00263	CcSEcCtD
Amitriptyline—Oedema—Mitoxantrone—sarcoma	0.000435	0.00262	CcSEcCtD
Amitriptyline—Decreased appetite—Dactinomycin—sarcoma	0.000435	0.00262	CcSEcCtD
Amitriptyline—Fatigue—Thiotepa—sarcoma	0.000435	0.00262	CcSEcCtD
Amitriptyline—Dysgeusia—Etoposide—sarcoma	0.000435	0.00261	CcSEcCtD
Amitriptyline—HTR2A—embryo—sarcoma	0.000435	0.00336	CbGeAlD
Amitriptyline—Hyperhidrosis—Vincristine—sarcoma	0.000432	0.0026	CcSEcCtD
Amitriptyline—Fatigue—Dactinomycin—sarcoma	0.000431	0.0026	CcSEcCtD
Amitriptyline—Constipation—Thiotepa—sarcoma	0.000431	0.00259	CcSEcCtD
Amitriptyline—Purpura—Epirubicin—sarcoma	0.000429	0.00258	CcSEcCtD
Amitriptyline—Shock—Mitoxantrone—sarcoma	0.000428	0.00258	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—sarcoma	0.000427	0.00257	CcSEcCtD
Amitriptyline—Thrombocytopenia—Mitoxantrone—sarcoma	0.000426	0.00257	CcSEcCtD
Amitriptyline—Anorexia—Vincristine—sarcoma	0.000426	0.00256	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—sarcoma	0.000425	0.00256	CcSEcCtD
Amitriptyline—Tachycardia—Mitoxantrone—sarcoma	0.000425	0.00256	CcSEcCtD
Amitriptyline—ADRA1A—lymphoid tissue—sarcoma	0.000422	0.00326	CbGeAlD
Amitriptyline—Cerebrovascular accident—Epirubicin—sarcoma	0.000421	0.00254	CcSEcCtD
Amitriptyline—Hyperhidrosis—Mitoxantrone—sarcoma	0.000421	0.00253	CcSEcCtD
Amitriptyline—Hypotension—Vincristine—sarcoma	0.000418	0.00251	CcSEcCtD
Amitriptyline—Feeling abnormal—Thiotepa—sarcoma	0.000415	0.0025	CcSEcCtD
Amitriptyline—Anorexia—Mitoxantrone—sarcoma	0.000415	0.0025	CcSEcCtD
Amitriptyline—CYP2B6—skin of body—sarcoma	0.000413	0.00319	CbGeAlD
Amitriptyline—ALB—testis—sarcoma	0.000413	0.00319	CbGeAlD
Amitriptyline—Osteoarthritis—Epirubicin—sarcoma	0.000413	0.00249	CcSEcCtD
Amitriptyline—Feeling abnormal—Dactinomycin—sarcoma	0.000412	0.00248	CcSEcCtD
Amitriptyline—Ill-defined disorder—Etoposide—sarcoma	0.000412	0.00248	CcSEcCtD
Amitriptyline—HTR7—tendon—sarcoma	0.000412	0.00318	CbGeAlD
Amitriptyline—HRH1—smooth muscle tissue—sarcoma	0.000409	0.00316	CbGeAlD
Amitriptyline—Hypotension—Mitoxantrone—sarcoma	0.000407	0.00245	CcSEcCtD
Amitriptyline—Insomnia—Vincristine—sarcoma	0.000404	0.00243	CcSEcCtD
Amitriptyline—Paraesthesia—Vincristine—sarcoma	0.000401	0.00242	CcSEcCtD
Amitriptyline—Urticaria—Thiotepa—sarcoma	0.000401	0.00241	CcSEcCtD
Amitriptyline—Malaise—Etoposide—sarcoma	0.0004	0.00241	CcSEcCtD
Amitriptyline—SIGMAR1—testis—sarcoma	0.000399	0.00308	CbGeAlD
Amitriptyline—Body temperature increased—Thiotepa—sarcoma	0.000399	0.0024	CcSEcCtD
Amitriptyline—Leukopenia—Etoposide—sarcoma	0.000397	0.00239	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—sarcoma	0.000397	0.00239	CcSEcCtD
Amitriptyline—Body temperature increased—Dactinomycin—sarcoma	0.000396	0.00238	CcSEcCtD
Amitriptyline—Paraesthesia—Mitoxantrone—sarcoma	0.000391	0.00235	CcSEcCtD
Amitriptyline—ALB—liver—sarcoma	0.000391	0.00302	CbGeAlD
Amitriptyline—Loss of consciousness—Etoposide—sarcoma	0.00039	0.00235	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—sarcoma	0.00039	0.00235	CcSEcCtD
Amitriptyline—Decreased appetite—Vincristine—sarcoma	0.000389	0.00234	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—sarcoma	0.000388	0.00234	CcSEcCtD
Amitriptyline—HTR2A—hematopoietic system—sarcoma	0.000388	0.003	CbGeAlD
Amitriptyline—Somnolence—Mitoxantrone—sarcoma	0.000387	0.00233	CcSEcCtD
Amitriptyline—Fatigue—Vincristine—sarcoma	0.000385	0.00232	CcSEcCtD
Amitriptyline—Convulsion—Etoposide—sarcoma	0.000384	0.00231	CcSEcCtD
Amitriptyline—Dyspepsia—Mitoxantrone—sarcoma	0.000383	0.00231	CcSEcCtD
Amitriptyline—Hypertension—Etoposide—sarcoma	0.000383	0.00231	CcSEcCtD
Amitriptyline—Constipation—Vincristine—sarcoma	0.000382	0.0023	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—sarcoma	0.000382	0.0023	CcSEcCtD
Amitriptyline—Decreased appetite—Mitoxantrone—sarcoma	0.000378	0.00228	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Epirubicin—sarcoma	0.000377	0.00227	CcSEcCtD
Amitriptyline—SIGMAR1—liver—sarcoma	0.000377	0.00291	CbGeAlD
Amitriptyline—Fatigue—Mitoxantrone—sarcoma	0.000375	0.00226	CcSEcCtD
Amitriptyline—HTR2A—connective tissue—sarcoma	0.000373	0.00289	CbGeAlD
Amitriptyline—Discomfort—Etoposide—sarcoma	0.000373	0.00225	CcSEcCtD
Amitriptyline—Constipation—Mitoxantrone—sarcoma	0.000372	0.00224	CcSEcCtD
Amitriptyline—Confusional state—Etoposide—sarcoma	0.000365	0.0022	CcSEcCtD
Amitriptyline—Asthenia—Thiotepa—sarcoma	0.000362	0.00218	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—sarcoma	0.000359	0.00216	CcSEcCtD
Amitriptyline—CYP3A4—hematopoietic system—sarcoma	0.000359	0.00277	CbGeAlD
Amitriptyline—Asthenia—Dactinomycin—sarcoma	0.000359	0.00216	CcSEcCtD
Amitriptyline—Feeling abnormal—Mitoxantrone—sarcoma	0.000359	0.00216	CcSEcCtD
Amitriptyline—CHRM3—testis—sarcoma	0.000358	0.00277	CbGeAlD
Amitriptyline—Pruritus—Thiotepa—sarcoma	0.000357	0.00215	CcSEcCtD
Amitriptyline—Thrombocytopenia—Etoposide—sarcoma	0.000355	0.00213	CcSEcCtD
Amitriptyline—SLC6A2—testis—sarcoma	0.000354	0.00273	CbGeAlD
Amitriptyline—Tachycardia—Etoposide—sarcoma	0.000353	0.00213	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—sarcoma	0.000353	0.00213	CcSEcCtD
Amitriptyline—Body temperature increased—Vincristine—sarcoma	0.000353	0.00213	CcSEcCtD
Amitriptyline—CYP2D6—hematopoietic system—sarcoma	0.000353	0.00273	CbGeAlD
Amitriptyline—Hyperhidrosis—Etoposide—sarcoma	0.00035	0.00211	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—sarcoma	0.000349	0.0021	CcSEcCtD
Amitriptyline—ADRA2A—cardiac atrium—sarcoma	0.000346	0.00268	CbGeAlD
Amitriptyline—Urticaria—Mitoxantrone—sarcoma	0.000346	0.00208	CcSEcCtD
Amitriptyline—Anorexia—Etoposide—sarcoma	0.000345	0.00208	CcSEcCtD
Amitriptyline—Diarrhoea—Thiotepa—sarcoma	0.000345	0.00208	CcSEcCtD
Amitriptyline—ADRA2A—uterus—sarcoma	0.000345	0.00266	CbGeAlD
Amitriptyline—Body temperature increased—Mitoxantrone—sarcoma	0.000344	0.00207	CcSEcCtD
Amitriptyline—Diarrhoea—Dactinomycin—sarcoma	0.000342	0.00206	CcSEcCtD
Amitriptyline—ORM1—lymph node—sarcoma	0.000342	0.00264	CbGeAlD
Amitriptyline—HTR2A—smooth muscle tissue—sarcoma	0.000342	0.00264	CbGeAlD
Amitriptyline—HTR7—testis—sarcoma	0.000341	0.00263	CbGeAlD
Amitriptyline—Pancytopenia—Epirubicin—sarcoma	0.000339	0.00204	CcSEcCtD
Amitriptyline—Hypotension—Etoposide—sarcoma	0.000338	0.00204	CcSEcCtD
Amitriptyline—CYP2B6—lymphoid tissue—sarcoma	0.000335	0.00259	CbGeAlD
Amitriptyline—Dizziness—Thiotepa—sarcoma	0.000333	0.00201	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—sarcoma	0.00033	0.00198	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—sarcoma	0.000327	0.00197	CcSEcCtD
Amitriptyline—Paraesthesia—Etoposide—sarcoma	0.000325	0.00196	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—sarcoma	0.000325	0.00195	CcSEcCtD
Amitriptyline—DRD2—testis—sarcoma	0.000322	0.00249	CbGeAlD
Amitriptyline—HTR7—liver—sarcoma	0.000322	0.00249	CbGeAlD
Amitriptyline—Somnolence—Etoposide—sarcoma	0.000322	0.00194	CcSEcCtD
Amitriptyline—Asthenia—Vincristine—sarcoma	0.000321	0.00193	CcSEcCtD
Amitriptyline—Vomiting—Thiotepa—sarcoma	0.000321	0.00193	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—sarcoma	0.000318	0.00192	CcSEcCtD
Amitriptyline—Vomiting—Dactinomycin—sarcoma	0.000318	0.00191	CcSEcCtD
Amitriptyline—Rash—Thiotepa—sarcoma	0.000318	0.00191	CcSEcCtD
Amitriptyline—Dermatitis—Thiotepa—sarcoma	0.000318	0.00191	CcSEcCtD
Amitriptyline—Headache—Thiotepa—sarcoma	0.000316	0.0019	CcSEcCtD
Amitriptyline—Rash—Dactinomycin—sarcoma	0.000315	0.0019	CcSEcCtD
Amitriptyline—Decreased appetite—Etoposide—sarcoma	0.000315	0.00189	CcSEcCtD
Amitriptyline—CYP2C19—liver—sarcoma	0.000315	0.00243	CbGeAlD
Amitriptyline—CYP2E1—lymphoid tissue—sarcoma	0.000314	0.00243	CbGeAlD
Amitriptyline—Pancytopenia—Doxorubicin—sarcoma	0.000314	0.00189	CcSEcCtD
Amitriptyline—Asthenia—Mitoxantrone—sarcoma	0.000312	0.00188	CcSEcCtD
Amitriptyline—Fatigue—Etoposide—sarcoma	0.000312	0.00188	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—sarcoma	0.000312	0.00188	CcSEcCtD
Amitriptyline—ADRA1A—liver—sarcoma	0.000311	0.0024	CbGeAlD
Amitriptyline—Jaundice—Epirubicin—sarcoma	0.00031	0.00187	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—sarcoma	0.00031	0.00187	CcSEcCtD
Amitriptyline—Constipation—Etoposide—sarcoma	0.00031	0.00186	CcSEcCtD
Amitriptyline—HRH1—tendon—sarcoma	0.000307	0.00238	CbGeAlD
Amitriptyline—Diarrhoea—Vincristine—sarcoma	0.000306	0.00184	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—sarcoma	0.000305	0.00184	CcSEcCtD
Amitriptyline—ADRA2A—tendon—sarcoma	0.000302	0.00233	CbGeAlD
Amitriptyline—Weight increased—Doxorubicin—sarcoma	0.000301	0.00181	CcSEcCtD
Amitriptyline—ALB—lymph node—sarcoma	0.0003	0.00232	CbGeAlD
Amitriptyline—Nausea—Thiotepa—sarcoma	0.000299	0.0018	CcSEcCtD
Amitriptyline—Feeling abnormal—Etoposide—sarcoma	0.000298	0.0018	CcSEcCtD
Amitriptyline—Diarrhoea—Mitoxantrone—sarcoma	0.000298	0.00179	CcSEcCtD
Amitriptyline—Nausea—Dactinomycin—sarcoma	0.000297	0.00179	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—sarcoma	0.000297	0.00179	CcSEcCtD
Amitriptyline—ABCB1—myometrium—sarcoma	0.000296	0.00229	CbGeAlD
Amitriptyline—Dizziness—Vincristine—sarcoma	0.000296	0.00178	CcSEcCtD
Amitriptyline—CYP2E1—tendon—sarcoma	0.000295	0.00228	CbGeAlD
Amitriptyline—Drowsiness—Doxorubicin—sarcoma	0.000295	0.00177	CcSEcCtD
Amitriptyline—CYP2C8—testis—sarcoma	0.000291	0.00224	CbGeAlD
Amitriptyline—SIGMAR1—lymph node—sarcoma	0.000289	0.00223	CbGeAlD
Amitriptyline—Neuropathy peripheral—Doxorubicin—sarcoma	0.000289	0.00174	CcSEcCtD
Amitriptyline—Urticaria—Etoposide—sarcoma	0.000288	0.00173	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—sarcoma	0.000287	0.00173	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—sarcoma	0.000287	0.00173	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—sarcoma	0.000286	0.00172	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—sarcoma	0.000286	0.00172	CcSEcCtD
Amitriptyline—ABCB1—embryo—sarcoma	0.000285	0.0022	CbGeAlD
Amitriptyline—Hypoaesthesia—Epirubicin—sarcoma	0.000284	0.00171	CcSEcCtD
Amitriptyline—Vomiting—Vincristine—sarcoma	0.000284	0.00171	CcSEcCtD
Amitriptyline—Rash—Vincristine—sarcoma	0.000282	0.0017	CcSEcCtD
Amitriptyline—Dermatitis—Vincristine—sarcoma	0.000282	0.00169	CcSEcCtD
Amitriptyline—Headache—Vincristine—sarcoma	0.00028	0.00169	CcSEcCtD
Amitriptyline—Vomiting—Mitoxantrone—sarcoma	0.000277	0.00167	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—sarcoma	0.000275	0.00165	CcSEcCtD
Amitriptyline—CYP2C8—liver—sarcoma	0.000275	0.00212	CbGeAlD
Amitriptyline—Rash—Mitoxantrone—sarcoma	0.000275	0.00165	CcSEcCtD
Amitriptyline—Dermatitis—Mitoxantrone—sarcoma	0.000274	0.00165	CcSEcCtD
Amitriptyline—Headache—Mitoxantrone—sarcoma	0.000273	0.00164	CcSEcCtD
Amitriptyline—ABCB1—seminal vesicle—sarcoma	0.000267	0.00207	CbGeAlD
Amitriptyline—Tinnitus—Epirubicin—sarcoma	0.000266	0.0016	CcSEcCtD
Amitriptyline—Nausea—Vincristine—sarcoma	0.000266	0.0016	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—sarcoma	0.000264	0.00159	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—sarcoma	0.000263	0.00158	CcSEcCtD
Amitriptyline—CYP2B6—testis—sarcoma	0.000261	0.00201	CbGeAlD
Amitriptyline—Asthenia—Etoposide—sarcoma	0.00026	0.00156	CcSEcCtD
Amitriptyline—Nausea—Mitoxantrone—sarcoma	0.000259	0.00156	CcSEcCtD
Amitriptyline—CYP1A2—liver—sarcoma	0.000257	0.00199	CbGeAlD
Amitriptyline—HTR2A—tendon—sarcoma	0.000257	0.00198	CbGeAlD
Amitriptyline—SLC6A2—lymph node—sarcoma	0.000256	0.00198	CbGeAlD
Amitriptyline—Pruritus—Etoposide—sarcoma	0.000256	0.00154	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—sarcoma	0.000255	0.00154	CcSEcCtD
Amitriptyline—HRH1—testis—sarcoma	0.000255	0.00197	CbGeAlD
Amitriptyline—ABCB1—hematopoietic system—sarcoma	0.000254	0.00196	CbGeAlD
Amitriptyline—Alopecia—Epirubicin—sarcoma	0.000252	0.00152	CcSEcCtD
Amitriptyline—ADRA2A—testis—sarcoma	0.00025	0.00193	CbGeAlD
Amitriptyline—CYP3A5—liver—sarcoma	0.000248	0.00192	CbGeAlD
Amitriptyline—Diarrhoea—Etoposide—sarcoma	0.000248	0.00149	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—sarcoma	0.000246	0.00148	CcSEcCtD
Amitriptyline—CYP2B6—liver—sarcoma	0.000246	0.0019	CbGeAlD
Amitriptyline—CYP2E1—testis—sarcoma	0.000245	0.00189	CbGeAlD
Amitriptyline—CYP2C9—liver—sarcoma	0.000244	0.00189	CbGeAlD
Amitriptyline—Dysgeusia—Epirubicin—sarcoma	0.000244	0.00147	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—sarcoma	0.000239	0.00144	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—sarcoma	0.000236	0.00142	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—sarcoma	0.000234	0.00141	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—sarcoma	0.000234	0.00141	CcSEcCtD
Amitriptyline—CYP2E1—liver—sarcoma	0.000231	0.00179	CbGeAlD
Amitriptyline—Ill-defined disorder—Epirubicin—sarcoma	0.000231	0.00139	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—sarcoma	0.00023	0.00139	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—sarcoma	0.000229	0.00138	CcSEcCtD
Amitriptyline—Rash—Etoposide—sarcoma	0.000228	0.00137	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—sarcoma	0.000228	0.00137	CcSEcCtD
Amitriptyline—Headache—Etoposide—sarcoma	0.000227	0.00137	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—sarcoma	0.000225	0.00136	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—sarcoma	0.000224	0.00135	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—sarcoma	0.000223	0.00134	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—sarcoma	0.000223	0.00134	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—sarcoma	0.00022	0.00132	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—sarcoma	0.000219	0.00132	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—sarcoma	0.000217	0.00131	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—sarcoma	0.000216	0.0013	CcSEcCtD
Amitriptyline—Nausea—Etoposide—sarcoma	0.000215	0.00129	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—sarcoma	0.000215	0.00129	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—sarcoma	0.000214	0.00128	CcSEcCtD
Amitriptyline—HTR2A—testis—sarcoma	0.000213	0.00164	CbGeAlD
Amitriptyline—Agitation—Doxorubicin—sarcoma	0.000211	0.00127	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—sarcoma	0.000211	0.00127	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—sarcoma	0.000209	0.00126	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—sarcoma	0.000208	0.00125	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—sarcoma	0.000207	0.00125	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—sarcoma	0.000206	0.00124	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—sarcoma	0.000206	0.00124	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—sarcoma	0.000205	0.00123	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—sarcoma	0.000203	0.00122	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—sarcoma	0.000203	0.00122	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—sarcoma	0.000202	0.00122	CcSEcCtD
Amitriptyline—HTR2A—liver—sarcoma	0.000201	0.00155	CbGeAlD
Amitriptyline—Shock—Epirubicin—sarcoma	0.0002	0.0012	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—sarcoma	0.000199	0.0012	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—sarcoma	0.000199	0.0012	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—sarcoma	0.000199	0.0012	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—sarcoma	0.000198	0.00119	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—sarcoma	0.000196	0.00118	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—sarcoma	0.000195	0.00117	CcSEcCtD
Amitriptyline—CYP2D6—testis—sarcoma	0.000194	0.0015	CbGeAlD
Amitriptyline—Discomfort—Doxorubicin—sarcoma	0.000194	0.00116	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—sarcoma	0.000193	0.00116	CcSEcCtD
Amitriptyline—ABCB1—uterus—sarcoma	0.000192	0.00148	CbGeAlD
Amitriptyline—Dry mouth—Doxorubicin—sarcoma	0.000192	0.00115	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—sarcoma	0.00019	0.00114	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—sarcoma	0.000189	0.00114	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—sarcoma	0.000188	0.00113	CcSEcCtD
Amitriptyline—CYP3A4—liver—sarcoma	0.000186	0.00144	CbGeAlD
Amitriptyline—Shock—Doxorubicin—sarcoma	0.000185	0.00111	CcSEcCtD
Amitriptyline—HRH1—lymph node—sarcoma	0.000184	0.00143	CbGeAlD
Amitriptyline—Thrombocytopenia—Doxorubicin—sarcoma	0.000184	0.00111	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—sarcoma	0.000184	0.0011	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—sarcoma	0.000183	0.0011	CcSEcCtD
Amitriptyline—CYP2D6—liver—sarcoma	0.000183	0.00141	CbGeAlD
Amitriptyline—Paraesthesia—Epirubicin—sarcoma	0.000182	0.0011	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—sarcoma	0.000182	0.00109	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—sarcoma	0.000181	0.0014	CbGeAlD
Amitriptyline—Somnolence—Epirubicin—sarcoma	0.00018	0.00109	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—sarcoma	0.000179	0.00108	CcSEcCtD
Amitriptyline—ABCB1—lymphoid tissue—sarcoma	0.000179	0.00138	CbGeAlD
Amitriptyline—Dyspepsia—Epirubicin—sarcoma	0.000179	0.00108	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—sarcoma	0.000176	0.00106	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—sarcoma	0.000176	0.00106	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—sarcoma	0.000175	0.00105	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—sarcoma	0.000174	0.00104	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—sarcoma	0.00017	0.00102	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—sarcoma	0.000169	0.00101	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—sarcoma	0.000167	0.00101	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—sarcoma	0.000167	0.001	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—sarcoma	0.000165	0.000995	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—sarcoma	0.000163	0.000983	CcSEcCtD
Amitriptyline—ABCB1—bone marrow—sarcoma	0.000163	0.00126	CbGeAlD
Amitriptyline—Fatigue—Doxorubicin—sarcoma	0.000162	0.000974	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—sarcoma	0.000161	0.00097	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—sarcoma	0.000161	0.000967	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—sarcoma	0.00016	0.000966	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—sarcoma	0.000155	0.000931	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—sarcoma	0.000149	0.000898	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—sarcoma	0.000148	0.000894	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—sarcoma	0.000146	0.000876	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—sarcoma	0.000144	0.000864	CcSEcCtD
Amitriptyline—ABCB1—testis—sarcoma	0.000139	0.00108	CbGeAlD
Amitriptyline—Diarrhoea—Epirubicin—sarcoma	0.000139	0.000836	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—sarcoma	0.000135	0.000811	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—sarcoma	0.000134	0.000808	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—sarcoma	0.000133	0.0008	CcSEcCtD
Amitriptyline—ABCB1—liver—sarcoma	0.000132	0.00102	CbGeAlD
Amitriptyline—Vomiting—Epirubicin—sarcoma	0.000129	0.000777	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—sarcoma	0.000129	0.000773	CcSEcCtD
Amitriptyline—Rash—Epirubicin—sarcoma	0.000128	0.00077	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—sarcoma	0.000128	0.00077	CcSEcCtD
Amitriptyline—Headache—Epirubicin—sarcoma	0.000127	0.000765	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—sarcoma	0.000124	0.000747	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—sarcoma	0.000121	0.000726	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—sarcoma	0.000119	0.000719	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—sarcoma	0.000118	0.000713	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—sarcoma	0.000118	0.000712	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—sarcoma	0.000118	0.000708	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—sarcoma	0.000112	0.000671	CcSEcCtD
Amitriptyline—ABCB1—lymph node—sarcoma	0.000101	0.00078	CbGeAlD
Amitriptyline—HTR1A—Signaling Pathways—MDM2—sarcoma	9.12e-06	6.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CCND1—sarcoma	9.12e-06	6.74e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CCND1—sarcoma	9.12e-06	6.74e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—EGFR—sarcoma	9.12e-06	6.74e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CTNNB1—sarcoma	9.12e-06	6.74e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KIT—sarcoma	9.11e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—NRAS—sarcoma	9.11e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—JUN—sarcoma	9.1e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—JUN—sarcoma	9.1e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—EGFR—sarcoma	9.1e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—VEGFA—sarcoma	9.1e-06	6.73e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MDM2—sarcoma	9.08e-06	6.71e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—EGFR—sarcoma	9.07e-06	6.71e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—SRC—sarcoma	9.07e-06	6.7e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—EGFR—sarcoma	9.04e-06	6.69e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CTNNB1—sarcoma	9.03e-06	6.68e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CTNNB1—sarcoma	9.03e-06	6.68e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—NRAS—sarcoma	8.98e-06	6.64e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—EGFR—sarcoma	8.95e-06	6.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—EGFR—sarcoma	8.93e-06	6.6e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—VEGFA—sarcoma	8.83e-06	6.53e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—HRAS—sarcoma	8.82e-06	6.52e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—KRAS—sarcoma	8.76e-06	6.47e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MYC—sarcoma	8.74e-06	6.46e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—NRAS—sarcoma	8.72e-06	6.45e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MDM2—sarcoma	8.69e-06	6.43e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—SRC—sarcoma	8.68e-06	6.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CREB1—sarcoma	8.67e-06	6.41e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—KRAS—sarcoma	8.61e-06	6.37e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MYC—sarcoma	8.61e-06	6.37e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MYC—sarcoma	8.6e-06	6.36e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—KRAS—sarcoma	8.6e-06	6.36e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PLCG1—sarcoma	8.58e-06	6.35e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—KRAS—sarcoma	8.57e-06	6.34e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EGFR—sarcoma	8.55e-06	6.32e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MYC—sarcoma	8.55e-06	6.32e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—KRAS—sarcoma	8.54e-06	6.32e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—HRAS—sarcoma	8.48e-06	6.27e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—KRAS—sarcoma	8.46e-06	6.26e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—VEGFA—sarcoma	8.46e-06	6.25e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—KRAS—sarcoma	8.44e-06	6.24e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—HRAS—sarcoma	8.43e-06	6.24e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EGFR—sarcoma	8.42e-06	6.23e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EGFR—sarcoma	8.41e-06	6.22e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MYC—sarcoma	8.37e-06	6.19e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EGFR—sarcoma	8.36e-06	6.18e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—NRAS—sarcoma	8.35e-06	6.18e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—EGFR—sarcoma	8.3e-06	6.14e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—SRC—sarcoma	8.24e-06	6.1e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EGFR—sarcoma	8.19e-06	6.05e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—sarcoma	8.18e-06	6.05e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—SRC—sarcoma	8.16e-06	6.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—SRC—sarcoma	8.16e-06	6.04e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL2—sarcoma	8.15e-06	6.03e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MYC—sarcoma	8.12e-06	6.01e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL2—sarcoma	8.11e-06	6e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—KRAS—sarcoma	8.08e-06	5.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—HRAS—sarcoma	8.07e-06	5.97e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—VEGFA—sarcoma	8.03e-06	5.94e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MDM2—sarcoma	8.01e-06	5.92e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—KRAS—sarcoma	7.96e-06	5.89e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—VEGFA—sarcoma	7.95e-06	5.88e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—VEGFA—sarcoma	7.95e-06	5.88e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—KRAS—sarcoma	7.95e-06	5.88e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CCND1—sarcoma	7.95e-06	5.88e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EGFR—sarcoma	7.95e-06	5.88e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—JUN—sarcoma	7.93e-06	5.87e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—NRAS—sarcoma	7.93e-06	5.86e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CCND1—sarcoma	7.91e-06	5.85e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—KRAS—sarcoma	7.9e-06	5.84e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—JUN—sarcoma	7.89e-06	5.84e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MDM2—sarcoma	7.88e-06	5.83e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CTNNB1—sarcoma	7.87e-06	5.82e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MDM2—sarcoma	7.87e-06	5.82e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—NRAS—sarcoma	7.85e-06	5.81e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—NRAS—sarcoma	7.85e-06	5.81e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MDM2—sarcoma	7.84e-06	5.8e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—KRAS—sarcoma	7.84e-06	5.8e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CTNNB1—sarcoma	7.83e-06	5.79e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—HRAS—sarcoma	7.83e-06	5.79e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MDM2—sarcoma	7.82e-06	5.78e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MYC—sarcoma	7.78e-06	5.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL2—sarcoma	7.76e-06	5.74e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MDM2—sarcoma	7.74e-06	5.72e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—KRAS—sarcoma	7.73e-06	5.72e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MDM2—sarcoma	7.72e-06	5.71e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—sarcoma	7.61e-06	5.63e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCND1—sarcoma	7.57e-06	5.6e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—JUN—sarcoma	7.55e-06	5.59e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—KRAS—sarcoma	7.51e-06	5.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	7.5e-06	5.54e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—HRAS—sarcoma	7.44e-06	5.5e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MYC—sarcoma	7.39e-06	5.46e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—HRAS—sarcoma	7.32e-06	5.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MYC—sarcoma	7.32e-06	5.41e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MYC—sarcoma	7.32e-06	5.41e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—HRAS—sarcoma	7.31e-06	5.4e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—HRAS—sarcoma	7.28e-06	5.39e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—HRAS—sarcoma	7.26e-06	5.37e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—sarcoma	7.22e-06	5.34e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—HRAS—sarcoma	7.19e-06	5.32e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KRAS—sarcoma	7.19e-06	5.32e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—sarcoma	7.18e-06	5.31e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MDM2—sarcoma	7.17e-06	5.3e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—HRAS—sarcoma	7.17e-06	5.3e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL2—sarcoma	7.16e-06	5.29e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—sarcoma	7.16e-06	5.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—sarcoma	7.16e-06	5.29e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—SRC—sarcoma	7.11e-06	5.26e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—SRC—sarcoma	7.08e-06	5.23e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—sarcoma	7.07e-06	5.23e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—sarcoma	7.07e-06	5.22e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL2—sarcoma	7.04e-06	5.21e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL2—sarcoma	7.03e-06	5.2e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—sarcoma	7.02e-06	5.19e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL2—sarcoma	7.01e-06	5.18e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL2—sarcoma	6.98e-06	5.16e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCND1—sarcoma	6.98e-06	5.16e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—JUN—sarcoma	6.96e-06	5.15e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—sarcoma	6.93e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL2—sarcoma	6.92e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CTNNB1—sarcoma	6.91e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL2—sarcoma	6.9e-06	5.1e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—sarcoma	6.89e-06	5.1e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—sarcoma	6.87e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCND1—sarcoma	6.87e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—HRAS—sarcoma	6.86e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—JUN—sarcoma	6.85e-06	5.07e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCND1—sarcoma	6.85e-06	5.07e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—NRAS—sarcoma	6.84e-06	5.06e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—JUN—sarcoma	6.84e-06	5.06e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCND1—sarcoma	6.83e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KRAS—sarcoma	6.82e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—JUN—sarcoma	6.82e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—NRAS—sarcoma	6.81e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCND1—sarcoma	6.81e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CTNNB1—sarcoma	6.8e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—JUN—sarcoma	6.79e-06	5.02e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CTNNB1—sarcoma	6.79e-06	5.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—SRC—sarcoma	6.78e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—HRAS—sarcoma	6.76e-06	5e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CTNNB1—sarcoma	6.76e-06	5e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KRAS—sarcoma	6.76e-06	5e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KRAS—sarcoma	6.76e-06	5e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—HRAS—sarcoma	6.76e-06	5e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCND1—sarcoma	6.74e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CTNNB1—sarcoma	6.74e-06	4.99e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—JUN—sarcoma	6.73e-06	4.98e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCND1—sarcoma	6.72e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—HRAS—sarcoma	6.71e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—JUN—sarcoma	6.71e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CTNNB1—sarcoma	6.68e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—sarcoma	6.67e-06	4.93e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—HRAS—sarcoma	6.66e-06	4.93e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	6.66e-06	4.92e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—sarcoma	6.6e-06	4.88e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HRAS—sarcoma	6.57e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NRAS—sarcoma	6.52e-06	4.82e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—sarcoma	6.41e-06	4.74e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—sarcoma	6.39e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—sarcoma	6.38e-06	4.72e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—sarcoma	6.38e-06	4.71e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—sarcoma	6.34e-06	4.69e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—sarcoma	6.25e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SRC—sarcoma	6.25e-06	4.62e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—sarcoma	6.24e-06	4.61e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—JUN—sarcoma	6.23e-06	4.61e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—sarcoma	6.2e-06	4.59e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	6.19e-06	4.57e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SRC—sarcoma	6.15e-06	4.55e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SRC—sarcoma	6.13e-06	4.54e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SRC—sarcoma	6.11e-06	4.52e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—sarcoma	6.11e-06	4.52e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SRC—sarcoma	6.09e-06	4.51e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—sarcoma	6.08e-06	4.5e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—sarcoma	6.07e-06	4.49e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—sarcoma	6.07e-06	4.49e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SRC—sarcoma	6.03e-06	4.46e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SRC—sarcoma	6.02e-06	4.45e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—sarcoma	6.01e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—sarcoma	6.01e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—sarcoma	6.01e-06	4.44e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—sarcoma	5.99e-06	4.43e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—sarcoma	5.97e-06	4.42e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—sarcoma	5.95e-06	4.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—sarcoma	5.94e-06	4.39e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—sarcoma	5.94e-06	4.39e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—sarcoma	5.91e-06	4.37e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—sarcoma	5.9e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—sarcoma	5.89e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—sarcoma	5.88e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—sarcoma	5.88e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—sarcoma	5.86e-06	4.34e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—sarcoma	5.86e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—sarcoma	5.86e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—sarcoma	5.81e-06	4.29e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—sarcoma	5.8e-06	4.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—sarcoma	5.79e-06	4.28e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—sarcoma	5.75e-06	4.25e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—sarcoma	5.75e-06	4.25e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—sarcoma	5.61e-06	4.15e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—sarcoma	5.6e-06	4.14e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SRC—sarcoma	5.59e-06	4.14e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—sarcoma	5.51e-06	4.07e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—sarcoma	5.5e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—sarcoma	5.48e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—sarcoma	5.48e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—sarcoma	5.46e-06	4.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—sarcoma	5.45e-06	4.03e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—sarcoma	5.41e-06	4e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—sarcoma	5.39e-06	3.99e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—sarcoma	5.39e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—sarcoma	5.38e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—sarcoma	5.38e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—sarcoma	5.36e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—sarcoma	5.34e-06	3.95e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—sarcoma	5.29e-06	3.91e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—sarcoma	5.27e-06	3.9e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—sarcoma	5.24e-06	3.87e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—sarcoma	5.21e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—sarcoma	5.17e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—sarcoma	5.09e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—sarcoma	5.08e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—sarcoma	5.06e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—sarcoma	5.05e-06	3.73e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—sarcoma	5.01e-06	3.71e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—sarcoma	5.01e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—sarcoma	5e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—sarcoma	4.99e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—sarcoma	4.98e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—sarcoma	4.98e-06	3.68e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—sarcoma	4.9e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—sarcoma	4.77e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—sarcoma	4.63e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—sarcoma	4.6e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—sarcoma	4.52e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—sarcoma	4.51e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—sarcoma	4.5e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—sarcoma	4.48e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—sarcoma	4.44e-06	3.28e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—sarcoma	4.43e-06	3.28e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—sarcoma	4.4e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—sarcoma	4.33e-06	3.2e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—sarcoma	4.32e-06	3.19e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—sarcoma	4.3e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—sarcoma	4.29e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—sarcoma	4.25e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—sarcoma	4.24e-06	3.13e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—sarcoma	4.12e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—sarcoma	3.94e-06	2.91e-05	CbGpPWpGaD
